Cazenove Group Limited Company Profile

21:32 EDT 20th March 2018 | BioPortfolio

Cazenove Group is a private company, registered in Jersey, which holds the 50% interest in JPMorgan Cazenove, the joint venture with JPMorgan.JPMorgan Cazenove is one of the UK's leading investment banks. Jointly owned by JPMorgan and Cazenove, it combines innovative and impartial advice with a broad range of capabilities and proven execution skills.
For further information on our Equities and International Capital Markets businesses please click on the following links.


20 Moorgate
United Kingdom


Phone: 44 (0)20 7155 5000
Fax: 44 (0)20 7155 9800

News Articles [343 Associated News Articles listed on BioPortfolio]

JPMorgan Cazenove provides wrong medicine for Shire, downgrading its rating to ‘neutral’

JPMorgan's analysts said: “Valuation remains undemanding, but with few 2018 or 2019 catalysts beyond a potential NeuroScience spin, which we do not see creating fundamental value, we struggle to see...

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Genetic Technologies Limited: Update on Strategic Alliance

MELBOURNE, Australia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), wishes to advise that the Company is presently in discussi...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of...

Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...

Quotient Limited Reports Second Quarter Fiscal 2018 Financial Results

MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...

Immutep Limited Announces Milestone Payment From Chinese Partner EOC Pharma

SYDNEY, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) announced today that it has received a milestone payment from the Company’s Chinese partner for efti...

Drugs and Medications [89 Associated Drugs and Medications listed on BioPortfolio]



Drug Facts

Donepezil hydrochloride [WOCKHARDT LIMITED]

These highlights do not include all the information needed to use donepezil hydrochloride tablets safely and effectively. See full prescribing information for donepezil hydrochloride tablets. Donepezi...


Famotidine Tablets, USP 20 mg

Facility maintenance instant hand sanitizer hs-67 [Knight Facilities Management, Inc.]

Facility Maintenance Instant Hand Sanitizer HS-67

PubMed Articles [1829 Associated PubMed Articles listed on BioPortfolio]

Transcanalicular laser-assisted dacryocystorhinostomy with diode laser.

This article compares the efficacy of transcanalicular laser assisted dacryocystorhinostomy (TL DCR) with conventional external dacryocystorhinostomy (Ex DCR). All patients were randomly divided into ...

Thirty first annual symposium on etiology, pathogenesis, and treatment of Parkinson disease and other movement disorders: Presented by the Parkinson study group, huntington study group, dystonia study group, tourette syndrome study group, cooperative ataxia group, and tremor research group.

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

Medulloblastoma, the most common malignant pediatric brain tumor, is a heterogeneous disease, with the existence of at least four molecular types: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Gro...

Application of the Pentafluorosulfanyl Group as a Bioisosteric Replacement.

The success of fluorinated molecules in drug design has led medicinal chemists to search for new fluorine-containing substituents. A major recently developed group is the pentafluorosulfanyl group. Th...

Systemic granulomatous disease in dairy cattle during a dicyandiamide feeding trial.

Mature, in-calf, non-lactating, Friesian or Friesian-cross cows were fed dicyandiamide (DCD) at daily doses of 0.15 g/kg (Group 1; n=31), 0.45 g/kg (Group 2; n=21) and 0.75 g/kg (Group 3; n=12), as pa...

Clinical Trials [3528 Associated Clinical Trials listed on BioPortfolio]

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

The Effect of Rhubarb on Sepsis and Post-traumatic Gastrointestinal Function Failure

Random grouping by computer, divided into two groups, a group of rhubarb treatment group, another group for the placebo group.

Companies [1674 Associated Companies listed on BioPortfolio]

Cazenove Group Limited

Cazenove Group is a private company, registered in Jersey, which holds the 50% interest in JPMorgan Cazenove, the joint venture with JPMorgan.JPMorgan Cazenove is one of the UK's leading investment ba...

ACE Group

Celebrating 25 years of insuring progress, the ACE Group is a global leader in insurance and reinsurance serving a diverse group of clients. Headed by ACE Limited (NYSE:ACE), a co...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Heritage Group LLC

Heritage Group is a unique venture capital firm with a track record of investing in, operating and advising innovative industry leading healthcare companies. Heritage Group serves...


The first unit of AARTI group, ALCHEMIE LABORATORIES, commenced commercial production of DIMETHYL SULPHATE (DMS) in the year 1975. Today, AARTI has acquired world-class expertise in the development an...

More Information about "Cazenove Group Limited" on BioPortfolio

We have published hundreds of Cazenove Group Limited news stories on BioPortfolio along with dozens of Cazenove Group Limited Clinical Trials and PubMed Articles about Cazenove Group Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cazenove Group Limited Companies in our database. You can also find out about relevant Cazenove Group Limited Drugs and Medications on this site too.

Quick Search


Relevant Topic

Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Corporate Database Quicklinks

Searches Linking to this Company Record